CTLA4 and Autoimmunity: Blockade of CTLA-4 with antibodies was shown to exacerbate disease in various mouse models of autoimmunity [16–18] and could even induce autoimmune manifestations in normal mice including gastritis, oophoritis, and mild sialoadenitis [19].